||10 VIAL, SINGLE-DOSE in 1 BOX > 5 mL in 1 VIAL, SINGLE-DOSE (61703-421-63)
||M.v.i. Pediatric What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
||Ascorbic Acid, Retinol, Ergocalciferol, Thiamine Hydrochloride, Riboflavin 5-phosphate Sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, .alpha.-tocopherol Acetate, Dl-, Biotin, Folic Acid, Cyanocobalamin, And Phytonadione What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
|11-Digit NDC Billing Format
||61703042153 NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
||EA - Billing unit of "each" is used when the product is dispensed in discreet units.
|RxNorm Crosswalk||1305200 and 1305205 - RxCUIs What is RxNorm?|
The RxNorm crosswalk provides a normalized naming system for generic and branded drugs by assigning unique concept identifiers (RxCUI) to each NDC.
||Human Prescription Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
||Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
- Intravenous - Administration within or into a vein or veins.
- ASCORBIC ACID 80 mg/5mL
- RETINOL .7 mg/5mL
- ERGOCALCIFEROL 10 ug/5mL
- THIAMINE HYDROCHLORIDE 1.2 mg/5mL
- RIBOFLAVIN 5'-PHOSPHATE SODIUM 1.4 mg/5mL
- PYRIDOXINE HYDROCHLORIDE 1 mg/5mL
- NIACINAMIDE 17 mg/5mL
- DEXPANTHENOL 5 mg/5mL
- .ALPHA.-TOCOPHEROL ACETATE, DL- 7 mg/5mL
- BIOTIN 20 ug/5mL
- FOLIC ACID 140 ug/5mL
- CYANOCOBALAMIN 1 ug/5mL
- PHYTONADIONE 200 ug/5mL
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Ascorbic Acid - [CS]
- Ergocalciferols - [CS]
- Provitamin D2 Compound - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin B 6 - [Chemical/Ingredient]
- Analogs/Derivatives - [Chemical/Ingredient]
- Vitamin B 12 - [CS]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Increased Prothrombin Activity - [PE] (Physiologic Effect)
- Reversed Anticoagulation Activity - [PE] (Physiologic Effect)
- Vitamin K - [CS]
- Vitamin K - [EPC] (Established Pharmacologic Class)
- Warfarin Reversal Agent - [EPC] (Established Pharmacologic Class)
||No Sample Package?
This field Indicates whether this package is a sample packaging or not.
||NDA - A product marketed under an approved New Drug Application. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
|FDA Application Number
||NDA018920 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
|Start Marketing Date
||07-01-2006 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
|Listing Expiration Date
||12-31-2021 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
||N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".